AGP Executive Report
Last update: an hour agoInnovation Lead: Switzerland remains No. 1 in the 2026 Global Innovation Index, holding the top spot since 2011. Roche Deal: The pharma group will pay China’s Rona Therapeutics $100 million upfront for an experimental obesity drug, with total payments potentially exceeding $1 billion. It is Roche’s fifth deal with a Chinese drugmaker since August. Weather Costs: Swiss Re estimates hail caused CHF1.7 billion in damage, adding to rising pressure on insurers and reinsurers. Banking and Housing: Swiss banks are looking to hire fewer staff, while mortgage rates rose in the third quarter.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
